Leber's hereditary optic neuropathy: Shifting our attention to the macula.

Leber's hereditary optic neuropathy Macular vascular pathology Optical coherence tomography angiography Subclinical vasculopathy

Journal

American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 20 09 2018
revised: 22 10 2018
accepted: 12 11 2018
entrez: 4 12 2018
pubmed: 7 12 2018
medline: 7 12 2018
Statut: epublish

Résumé

Peripapillary vascular alterations have been classically described as hallmarks of Leber's Hereditary Optic Neuropathy (LHON). We recently demonstrated microvascular pathology involving the macula in patients affected with chronic LHON using optical coherence tomography angiography (OCTA). Macular vascular pathology in acute LHON has not previously been reported. The macular superficial vasculature of an asymptomatic carrier and an affected patient with acute LHON, mitochondrial DNA mutation 3460, was assessed by OCTA. Similar findings of peripapillary microangiopathy and vascular telangiectasias were seen the affected patient, but in the parafoveal macula. These changes were most prominent nasally and inferiorly, corresponding to the proximal portions of the papillomacular bundle. The foveal avascular zone was markedly enlarged in the affected patient relative to the asymptomatic mother. These findings in acute LHON further supports the clinical utility of vascular parameters and suggest that further studies focused on macular pathology may be warranted to assess the natural history of LHON.

Identifiants

pubmed: 30505979
doi: 10.1016/j.ajoc.2018.11.010
pii: S2451-9936(18)30425-0
pmc: PMC6247405
doi:

Types de publication

Journal Article

Langues

eng

Pagination

13-15

Références

Clin Exp Ophthalmol. 2013 Sep-Oct;41(7):702-12
pubmed: 23433229
Br J Ophthalmol. 2016 Sep;100(9):1232-7
pubmed: 26614631
Arch Ophthalmol. 1982 Oct;100(10):1597-602
pubmed: 7138328
Invest Ophthalmol Vis Sci. 2012 Nov 09;53(12):7608-17
pubmed: 23060142
Arch Ophthalmol. 1983 Jul;101(7):1059-68
pubmed: 6870629
Am J Ophthalmol. 2018 Aug;192:217-228
pubmed: 29885298

Auteurs

Samuel Asanad (S)

Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.

Elana Meer (E)

Perelman School of Medicine, University of Pennsylvania, Penn, USA.

Michele Fantini (M)

Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, University of Udine, Udine, Italy.

Enrico Borrelli (E)

Doheny Eye Institute, Los Angeles, CA, USA.
Ophthalmology Clinic, Department of Medicine and Science of Ageing, University G. D'Annunzio Chieti-Pescara, Chieti, Italy.

Alfredo A Sadun (AA)

Doheny Eye Institute, Los Angeles, CA, USA.
Department of Ophthalmology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.

Classifications MeSH